Risk of Ovarian Malignancy algorithm (ROMA) test is used as an aid in assessing the risk of Ovarian cancer in women with a pelvic mass based on patient’s HE4 & CA125 levels and their menopausal status. Women with ROMA levels above their cutoff have an increased risk of Ovarian cancer. ROMA must be interpreted in conjunction with clinical & radiological assessment.